|
1
|
Knudsen K and Kelly WK: Outsmarting
androgen receptor: creative approaches for targeting aberrant
androgen signaling in advanced prostate cancer. Expert Rev
Endocrinol Metab. 6:483–493. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gao F, Yang M, Luo L and Wu XH: Local
insulin-like growth factor-I of ventral prostate was upregulated
during long-term castration and may function through the autocrine
system. Prostate Cancer Prostatic Dis. 14:136–142. 2011. View Article : Google Scholar
|
|
3
|
Culig Z and Puhr M: Interleukin-6: a
multifunctional targetable cytokine in human prostate cancer. Mol
Cell Endocrinol. 360:52–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mohler JL, Gregory CW, Ford OH III, Kim D,
Weaver CM, Petrusz P, Wilson EM and French FS: The androgen axis in
recurrent prostate cancer. Clin Cancer Res. 10:440–448. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mohler JL: Castration-recurrent prostate
cancer is not androgen-independent. Adv Exp Med Biol. 617:223–234.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scher HI and Sawyers CL: Biology of
progressive, castration-resistant prostate cancer: directed
therapies targeting the androgen-receptor signaling axis. J Clin
Oncol. 23:8253–8261. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Imamura T: Epigenetic setting for
long-term expression of estrogen receptor α and androgen receptor
in cells. Horm Behav. 59:345–352. 2011.PubMed/NCBI
|
|
8
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar
|
|
9
|
Gao L and Alumkal J: Epigenetic regulation
of androgen receptor signaling in prostate cancer. Epigenetics.
5:100–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martinez-Arguelles DB and Papadopoulos V:
Epigenetic regulation of the expression of genes involved in
steroid hormone biosynthesis and action. Steroids. 75:467–476.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Terao Y, Nishida J, Horiuchi S, Rong F,
Ueoka Y, Matsuda T, Kato H, Furugen Y, Yoshida K, Kato K and Wake
N: Sodium butyrate induces growth arrest and senescence-like
phenotypes in gynecologic cancer cells. Int J Cancer. 94:257–267.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jüttermann R, Li E and Jaenisch R:
Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated
primarily by covalent trapping of DNA methyltransferase rather than
DNA demethylation. Proc Natl Acad Sci USA. 91:11797–11801.
1994.
|
|
13
|
Zorn CS, Wojno KJ, McCabe MT, Kuefer R,
Gschwend JE and Day ML: 5-Aza-2′-deoxycytidine delays
androgen-independent disease and improves survival in the
transgenic adenocarcinoma of the mouse prostate mouse model of
prostate cancer. Clin Cancer Res. 13:2136–2143. 2007.
|
|
14
|
McCabe MT, Low JA, Daignault S, Imperiale
MJ, Wojno KJ and Day ML: Inhibition of DNA methyltransferase
activity prevents tumorigenesis in a mouse model of prostate
cancer. Cancer Res. 66:385–392. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gravina GL, Marampon F, Di Staso M,
Bonfili P, Vitturini A, Jannini EA, Pestell RG, Tombolini V and
Festuccia C: 5-Azacitidine restores and amplifies the bicalutamide
response on preclinical models of androgen receptor expressing or
deficient prostate tumors. Prostate. 70:1166–1178. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu HC, Hsieh JT, Gleave ME, Brown NM,
Pathak S and Chung LW: Derivation of androgen independent human
LNCaP prostatic cancer cell sublines: role of bone stromal cells.
Int J Cancer. 57:406–412. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carmichael J, DeGraff WG, Gazdar AF, Minna
JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated
colorimetric assay: assessment of chemosensitivity testing. Cancer
Res. 47:936–942. 1987.PubMed/NCBI
|
|
18
|
Malikova J, Swaczynova J, Kolar Z and
Strnad Z: Anticancer and antiproliferative activity of natural
brassinosteroids. Phytochemistry. 69:418–426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tilley WD, Marcelli M and McPhaul MJ:
Expression of the human androgen receptor gene utilizes a common
promoter in diverse human tissues and cell lines. J Biol Chem.
265:13776–13781. 1990.PubMed/NCBI
|
|
20
|
Trtkova K, Paskova L, Matijescukova N,
Strnad M and Kolar Z: Binding of AR to SMRT/N-CoR complex and its
co-operation with PSA promoter in prostate cancer cells treated
with natural histone deacetylase inhibitor NaB. Neoplasma.
57:406–414. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jarrard DF, Kinoshita H, Shi Y, Sandefur
C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB and Nassif N:
Methylation of the androgen receptor promoter CpG island is
associated with loss of androgen receptor expression in prostate
cancer cells. Cancer Res. 58:5310–5314. 1998.PubMed/NCBI
|
|
22
|
Nakayama T, Watanabe M, Suzuki H, Toyota
M, Sekita N, Hirokawa Y, Mizokami A, Ito H, Yatani R and Shiraishi
T: Epigenetic regulation of androgen receptor gene expression in
human prostate cancers. Lab Invest. 80:1789–1796. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kinoshita H, Shi Y, Sandefur C, Meisner
LF, Chang C, Choon A, Reznikoff CR, Bova GS, Friedl A and Jarrard
DF: Methylation of the androgen receptor minimal promoter silences
transcription in human prostate cancer. Cancer Res. 60:3623–3630.
2000.PubMed/NCBI
|
|
24
|
Mancini DN, Singh SM, Archer TK and
Rodenhiser DI: Site-specific DNA methylation in the
neurofibromatosis (NF1) promoter interferes with binding of CREB
and SP1 transcription factors. Oncogene. 18:4108–4119. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mishra DK, Chen Z, Wu Y, Sarkissyan M,
Koeffler HP and Vadgama JV: Global methylation pattern of genes in
androgen-sensitive and androgen-independent prostate cancer cells.
Mol Cancer Ther. 9:33–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cameron EE, Bachman KE, Myöhänen S, Herman
JG and Baylin SB: Synergy of demethylation and histone deacetylase
inhibition in the re-expression of genes silenced in cancer. Nat
Genet. 21:103–107. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dobosy JR and Selker EU: Emerging
connections between DNA methylation and histone acetylation. Cell
Mol Life Sci. 58:721–727. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ahmed H: Promoter methylation in prostate
cancer and its application for the early detection of prostate
cancer using serum and urine samples. Biomark Cancer. 2:17–33.
2010. View Article : Google Scholar
|
|
29
|
Emanuele S, Lauricella M and Tesoriere G:
Histone deacetylase inhibitors: apoptotic effects and clinical
implications (Review). Int J Oncol. 33:637–646. 2008.PubMed/NCBI
|
|
30
|
Marks PA and Xu WS: Histone deacetylase
inhibitors: potential in cancer therapy. J Cell Biochem.
107:600–608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu WG and Otterson GA: The interaction of
histone deacetylase inhibitors and DNA methyltransferase inhibitors
in the treatment of human cancer cells (Review). Curr Med Chem
Anticancer Agents. 3:187–199. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
VanOosten RL, Earel JK Jr and Griffith TS:
Histone deacetylase inhibitors enhance Ad5-TRAIL killing of
TRAIL-resistant prostate tumor cells through increased caspase-2
activity. Apoptosis. 12:561–571. 2007. View Article : Google Scholar
|
|
33
|
Qiu J, Gao Z and Shima H: Growth of human
prostate cancer cells is significantly suppressed in vitro
with sodium butyrate through apoptosis. Oncol Rep. 27:160–167.
2012.PubMed/NCBI
|
|
34
|
Walton TJ, Li G, Seth R, McArdle SE,
Bishop MC and Rees RC: DNA demethylation and histone deacetylation
inhibition co-operate to re-express estrogen receptor beta and
induce apoptosis in prostate cancer cell-lines. Prostate.
68:210–222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tilley WD, Bentel JM, Aspinall JO, Hall RE
and Horsfall DJ: Evidence for a novel mechanism of androgen
resistance in the human prostate cancer cell line, PC-3. Steroids.
60:180–186. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mizokami A and Chang C: Induction of
translation by the 5′-untranslated region of human androgen
receptor mRNA. J Biol Chem. 269:25655–25659. 1994.
|
